Why do bv symptoms come and go

Content on WhatAnswers is provided "as is" for informational purposes. While we strive for accuracy, we make no guarantees. Content is AI-assisted and should not be used as professional advice.

Last updated: April 8, 2026

Quick Answer: Bacterial vaginosis (BV) symptoms come and go due to fluctuations in vaginal pH and bacterial balance. Approximately 50% of women with BV experience recurrent episodes within 12 months. Symptoms typically include thin, grayish-white discharge with a fishy odor, which may worsen after sexual intercourse or during menstruation. Treatment with antibiotics like metronidazole clears initial infections in 80-90% of cases, but recurrence remains common.

Key Facts

Bacterial vaginosis affects 29% of U.S. women aged 14-49 according to CDC data
Recurrence rates reach 50% within 12 months of initial treatment
Normal vaginal pH is 3.8-4.5, while BV elevates it above 4.5
Metronidazole treatment shows 80-90% initial cure rates
Douching increases BV risk by 2-3 times compared to non-douchers

Overview

Bacterial vaginosis (BV) represents the most common vaginal infection among reproductive-age women, first described in medical literature in 1955. The condition occurs when the normal balance of vaginal bacteria shifts, with Lactobacillus species decreasing while anaerobic bacteria like Gardnerella vaginalis, Prevotella, and Mobiluncus increase. According to CDC surveillance data, BV prevalence varies by population, affecting approximately 29% of U.S. women aged 14-49, with higher rates among Black women (51%) compared to White women (23%). The condition's fluctuating nature has been documented since the 1980s, when researchers began tracking recurrence patterns. BV diagnosis typically involves Amsel criteria (three of four: thin discharge, pH >4.5, positive whiff test, clue cells) or Nugent scoring of Gram-stained vaginal smears. The economic impact is substantial, with annual U.S. healthcare costs exceeding $1 billion for diagnosis and treatment.

How It Works

BV symptoms fluctuate due to dynamic changes in the vaginal microbiome and pH levels. Normally, Lactobacillus species maintain vaginal acidity (pH 3.8-4.5) by producing lactic acid and hydrogen peroxide, which suppress pathogenic bacteria. In BV, this protective environment breaks down as Lactobacillus decreases, allowing anaerobic bacteria to proliferate and produce amines like putrescine and cadaverine. These volatile compounds create the characteristic fishy odor, particularly noticeable when vaginal pH rises during menstruation or after semen exposure (semen has pH 7.1-8.0). The vaginal epithelium responds by increasing discharge production to flush out bacteria. Recurrence happens because antibiotic treatments like metronidazole (500mg twice daily for 7 days) or clindamycin don't always restore long-term Lactobacillus dominance. Behavioral factors including douching, new sexual partners, and smoking can repeatedly disrupt the microbial balance, while some women may have genetic predispositions affecting their ability to maintain healthy flora.

Why It Matters

BV's recurring nature has significant health implications beyond discomfort. The condition doubles the risk of acquiring sexually transmitted infections including HIV, gonorrhea, and chlamydia by compromising the vaginal mucosal barrier. Pregnant women with BV face increased risks of preterm delivery (1.5-2 times higher), low birth weight, and postpartum endometritis. The psychological impact is substantial, with studies showing decreased sexual satisfaction and quality of life scores among women with recurrent BV. From a public health perspective, BV's association with HIV transmission makes it a concern in global HIV prevention efforts. Research continues into probiotics containing Lactobacillus strains and biofilm-disrupting agents to prevent recurrences, addressing a condition that affects millions of women worldwide with patterns that remain unpredictable despite current treatments.